Intestinal Microbiome Changes and Clinical Outcomes of Patients with Ulcerative Colitis after Fecal Microbiota Transplantation.

Background And Aims: Ulcerative colitis (UC) is a chronic inflammatory disease that affects many people. One of the possible ways to treat UC is fecal microbiota transplantation (FMT). In this study, changes in the intestinal microbiome and clinical outcomes of 20 patients with UC after FMT were estimated.

[Malignant lymphomas of the gastrointestinal tract (problems of histogenesis, morphogenesis and histological diagnosis)].

Seventy malignant lymphomas of the gastro-intestinal tract (GIT) (54 lymphosarcomas, 16 lymphogranulomatoses) were studied. GIT lymphosarcomas and lymphogranulomatosis are characterized by the similarity of histogenesis, morphogenesis, and forms of progression. The lymphoid apparatus of GIT is the source of tumor growth, the tumor develops multicentrically and not simultaneously, the progression occurs as autochthonous growth, metastasizing.